Nasrat Hakim | President and CEO |
Carter Ward | Chief Financial Officer |
Good morning, ladies and gentlemen. And welcome to the Elite Pharmaceuticals’ Conference Call. At this time, all lines have been placed on listen-only mode.
Before the management begins speaking, the company asked the following statement. This conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to the effect, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this conference call.